A two-drug combination for treating advanced kidney cancer has shown sustained and durable clinical benefit in more than five ...

A global study reveals that cutting-edge cancer immunotherapies, while lifesaving, carry a hidden risk: they may trigger ...

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its ...

Facing patent expiration for its blockbuster Keytruda, Merck aims to streamline operations with significant job cuts and ...

NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announces that it will implement the Company’s previously disclosed plans to change the ratio of its American Depository Shares (“ADSs”) to its ...

This funding will allow LiFT to take its immuno-modulatory alpha neutrophil (IMAN)-based therapy to Phase I clinical trials ...

Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of ...

O penAI has removed a feature from ChatGPT which allowed people to make their conversations discoverable by search engines ...